Agena Bioscience®, the global manufacturer of the MassARRAY® System for targeted genetic analysis has signed an exclusive distribution agreement with Alliance Global (AGBL Group) to bring the MassARRAY technology to many emerging markets across the Middle East, Africa, and Central Asia.

“With their extensive biomedical distribution network, AGBL is an ideal partner to bring our high-throughput, low-cost, targeted genotyping solution to these emerging healthcare markets,” said Roman Haehn, Senior Vice President of Commercial Operations at Agena Bioscience. “We are very pleased to partner with AGBL for their comprehensive commercial coverage in the life science and clinical diagnostics markets.”

“As the leading provider of genomics research and testing solutions in the region, we are confident that our partnership with Agena Bioscience will provide our customers with a highly accurate, robust, and flexible platform for their growing research and clinical needs,” said Dr. Nassim-Marie Hambouz, Group Vice President at AGBL.

Please read the Press Release